Feb 24, 2022
461
Dante Labs, a global leader in genomics and precision medicine, today announced it has partnered with The Renato Dulbecco Foundation to deliver more personalized therapies in rare diseases, oncology and COVID-19.
Protelica, the groundbreaking US biotechnology company, has licensed its library of billions of pronectines nanoantibodies and a portfolio of 12 patents to The Renato Dulbecco Foundation.
SOURCE: https://www.streetinsider.com
You may be interested
-
'Phantom Limb': A Conversation With Dennis...
Dennis Palumbo is a thriller writer and psychotherapist in private practice. He's the auth...
-
Arnaldo Trabucco, celebrated medical practit...
Arnaldo Trabucco, MD, FACS is a leading urologist who received his medical training at ins...
-
Exciting Palatine. Interview with Clementina...
You can tell she fills with excitement when she has the chance to show an important archae...
-
ISSNAF medical imaging science chapter meeti...
AGENDA 12.00 – 12.15 Light lunch12.15 – 12.30Welcome addresses Lorenzo Mannelli, MD, PhD...
-
Italy, the importance of innovation for agri...
by Claudia Astarita The food farming sector is still one of the engines of Italia...
-
'A summer without travel': How long will Ital...
As the Italian government prepares to bring in “phase two” of the national lockdown measur...
-
'Alone': How Italian town with 1st known viru...
Italy delivered the first shocking confirmation of locally transmitted coronavirus infecti...
-
'Buffalo lost a part of its soul': Joey Giamb...
The first line in the email said everything. "Buffalo lost a part of its soul yesterday wi...
